The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)

EuroIntervention 2017;13:1312-1319 published online August 2017. DOI: 10.4244/EIJ-D-17-00330

1. Medizinische Klinik I, Department of Cardiology, University of Giessen, Giessen, Germany; 2. Deutsches Herzzentrum München, Munich, Germany; 3. Department of Cardiology, University of Vienna Medical School, Vienna, Austria; 4. Department of Cardiology,

Aims: The aim of this study was to analyse the procedural results and midterm safety of everolimus-eluting bioresorbable vascular scaffolds (BVS) used for percutaneous coronary interventi

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R